Clinical Trial: Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013747) titled 'Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne' on June 02.

Brief Summary: The purpose of the VBE00009 study is to evaluate the safety, efficacy and immunogenicity of 2 administrations of the Acne mRNA vaccine candidate at single dose level in participants aged 18 to 45 years with mild acne. This study will consist of a Sentinel Cohort and a Main Cohort, with the Sentinel Cohort assessing the safety in a stepwise manner.

Study Start Date: June 06

Study Type: INTERVENTIONAL

Condition: Acne

Intervention: BIOLOGICAL: Acne mRNA vaccine

Pharmaceutical form: suspension for ...